Dr Anji Anand
Consultant Clinical Oncologist
MBBS, MSc, MRCP, FRCR
Speciality
Radiotherapy, Chemotherapy, Hormonal Therapy, Biological Therapy
Current NHS Post
Nottingham City Hospital
Year Qualified
1996
Clinical Interests
Cervical cancer, concurrent chemo-radiotherapy, HDR brachytherapy, uterine cancers, Intensity modulated radiotherapy, ovarian cancers, adjuvant and palliative chemotherapy, VEGF inhibitors, PARP inhibitors, adjuvant breast radiotherapy, advanced breast cancers, palliative chemotherapy for breast cancers, palliative radiotherapy for pain control, endocrine treatment for breast cancers, monoclonal antibody treatment
Research Interests
Ovarian Cancer, Breast Radiotherapy
Professional Memberships
- Fellow of the Royal College of Radiologists
- European Society of Gynaecological Oncology
- European Society of Radiology and Oncology
Biography
Dr Anji Anand is currently working as a Consultant Clinical Oncologist at Nottingham University Hospitals NHS trust. She has been in this post since 2010. Prior to her appointment as a consultant she trained as specialist registrar at Nottingham University Hospitals, Derby Royal Infirmary and University Hospitals of Leicester. Her special interests are gynaecological cancers and breast cancers. She is the Lead Clinician instrumental in the development of HDR intracavitary brachytherapy for cervical and uterine cancers. In addition, she also treats ovarian cancer and has a special interest in the use of PARP inhibitors. She also treats patients with breast cancer using appropriate modalities of treatment- chemotherapy, adjuvant and palliative radiotherapy and endocrine treatment.